Skip to content
Recall Observatory FDA recall evidence

Device product

DrugSmart Dip (MET/OPI2)+AMP+BZO+COC+THC, Item No. 30600D; DrugSmart Dip AMP/OPI2/COC/THC/BZO Test, Item No. 30520D These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0309-2016

October 20, 2015

Class II

Product summary

Firm
Ameditech Inc
Event
Event 72471
Status
Terminated
Classification
Class II
Quantity
160 units
Official record key
device-enforcement:Z-0309-2016

Official wording

Reason: Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information: 141379 144260 150225

Distribution pattern: Worldwide Distribution - US (nationwide) and Internationally to Australia.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Ameditech is recalling drug abuse tests because they have shown reduced reactivity.